Wednesday 10 January 2018

Integrated Pest Management Market Value Is Anticipated To Grow By 2025 Owing To Increasing Pest Population Due To Change In Climate Conditions : Grand View Research, Inc.

The global integratedpest management market value is anticipated to reach USD 151.0 billion by 2025, according to a new report by Grand View Research, Inc. Favorable regulatory scenario banning the usage of pesticides and growing concerns regarding the diseases caused by insects are anticipated to favor industry growth.
IPM program is a systematic approach used for solving insect, weed, & diseases problems and prevent them from damaging crops, infesting buildings, & harming animals. It is the most effective and least-risk options for responding to the problem. The approach can be used to manage all kinds of insect anywhere such as in urban, wildland, agricultural, and natural areas.
The rising concern over harmful effects of pesticides on the environment is likely to enhance the popularity of the product. Some of the major application sectors of the industry include agriculture, commercial buildings, industrial, residential, and others. Agricultural is the largest application segment and is expected to follow the same growth trend over the forecast period, owing to its usage in controlling and preventing the insect from crops.
Invertebrates have emerged as the largest segment in 2016 followed by weeds, pathogens, and vertebrates. Change in climate conditions and rising temperature is anticipated to be the major factor for the growth of invertebrate. Invertebrates are generally the household insect including ants, cockroaches, flies, and caterpillars. They can harm the household farming thus leading to infect human health and environment. The IPM program and training may help in mitigating the risk of invertebrate control with reducing the utilization of chemicals and increasing efficiency.
Further key findings from the report suggest:
·         The global demand for integrated pest management market was valued at USD 91.8 billion in 2016. The market is anticipated to grow to USD 151 billion by 2025, growing at a CAGR of 5.8% from 2017 to 2025.
·         Chemical control approach dominated the market in 2016 followed by mechanical & physical, biological, cultural, and others method.
·         Agricultural is largest application segment and is projected to follow the same growth trend over the forecast period.
·         The North America and Europe region was the largest regional market with a combined share of over 56%.
·         Asia Pacific region is anticipated to have the fastest growth. the region is projected to grow at a CAGR of 6.4% from 2017 to 2025.
·         The industry is dominated by a few multinational corporations such as BASF SE, Advanced Integrated Pest Management, IPM Pest Control, SGS SA, MB Integrated Pest Control, Bayer CropScience LP, Ecolab Inc., IPM Technologies Pty Ltd, and Integrated Pest Management Solution (IPMS India).
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers
Grand View Research has segmented the global integrated pest management market by pest type, control method, application, and region:
Integrated Pest Management Pest Type Outlook (Revenue, USD Million, 2014 - 2025)
·         Weeds
·         Invertebrates
·         Pathogens
·         Vertebrates
Integrated Pest Management Control Method Outlook (Revenue, USD Million, 2014 - 2025)
·         Biological Control
·         Chemical Control
·         Cultural Controls
·         Mechanical & Physical Controls
·         Other Control Method
Integrated Pest Management Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Agriculture
·         Commercial buildings
·         Industrial
·         Residential
·         Others
Integrated Pest Management Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    UK
o    Netherland
o    Germany
·         Asia Pacific
o    China
o    India
·         Central & South America
o    Brazil
·         Middle East & Africa
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-integrated-pest-management-ipm-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


Cell Surface Marker Detection Market Is Expected To Grow Due To Growing Automation In Laboratories Till 2022 : Grand View Research, Inc.

The global cellsurface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 
Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years. 
Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 
Further key findings from the report suggest:
·         Flow cytometry devices accounted for over 70% of the revenue generated in the industry for 2014. This large share can be attributed to the growing advancement in these instruments such as enhancement in efficiency and resolution of fluorescence-based cytometric detectors. Furthermore, presence of large product portfolio of different industry players operating in cytometry is responsible for large market share of this technique. 
·         Disease diagnosis and identification accounted for over 50% of the revenue generated in the market for 2014. High incidence rate of cell-associated disorders and oncology diseases that need to be treated in order to curb the mortality rate are the major drivers for growth of this segment. 
·         Determination of novel drug targets and development of biopharmaceuticals for prognosis of chronic diseases is anticipated to propel growth of research and drug discovery sub-segment in the coming years. With expected development of this segment, the sector will witness lucrative growth over the forecast period. 
·         North America accounted for the largest share of this sector for 2014, as there are is significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional growth. 
·         North America dominated the industry in 2014, with revenue estimated at USD 999.0 million. Presence of sophisticated healthcare infrastructure and favorable government initiatives with respect to analytical techniques and their applications for disease diagnosis and drug development are some key factors likely to drive growth. 
·         Asia Pacific is expected to witness lucrative growth from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment and growing medical expenditures in emerging economies of India and China 
·         Key participants of the cell surface marker detection industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd. 
·         These participants are involved in R&D for production of cell-specific antibodies and collaborations with smaller entities operating in the market as well as with academic research laboratories in order to maintain their market position and enter the untapped market regions 
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented cell surface marker detection market on the basis of product, application, and region:
Cell Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
·         Flow Cytometry
·         Hematology Analyzers
·         Reagents & Kits
Cell Surface Marker Detection Application Outlook (Market Revenue in USD Million, 2012 - 2022 )
·         Disease Diagnosis & Identification
·         Research & Drug Discovery
·         Others
Cell Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )
·         North America
·         Europe
·         Asia Pacific
·         RoW
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-cell-surface-marker-detection-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com










Medical Cameras Market Is Expected To Grow Due To Increasing Preference To Capture High Resolution Digital Images By 2025: Grand View Research, Inc.

The global medical cameras market is expected to reach a value of USD 18.06 billion by 2025, according to a new report by Grand View Research, Inc. Medical cameras have gained an indispensable position in modern medicine. Images and videos released from medical cameras are currently used across life science applications where visual study requires documentation. These cameras find an array of application majorly in microscopy, ophthalmology, pathology, endoscopy, lab automation, biomedical research, rheumatology, and other specialties.
These products ensure accurate diagnosis thereby facilitating the doctors to make precise and appropriate interpretations. Performance benchmarks are increasing to ensure better healthcare delivery, owing to the increasing private funding and investments in healthcare facilities and infrastructure. Consistent technological advancements coupled with increased acceptance and application of products is expected to exhibit good market growth during the forecast period. However, medical images and videos are highly sensitive healthcare records and hence use of camera technologies and products are restrained.
The market on the basis of application is witnessing significant growth in the endoscopy segment, owing to wide range of use in examinations of the gastrointestinal tract, the respiratory tract and other procedures such as laparoscopy, arthroscopy, cystoscopy, obstetrics, bronchoscopy, laryngoscopy, mediastinoscopy and others. By technology, digital imaging (2D/3D) segment occupied the largest market share, owing to several advantages such as instant examination of the images, and can be recaptured if necessary and no film purchase or development costs are involved.
Further Key Findings From the Study Suggest:
·         Endoscopy is the largest segment, owing to the rising demand for minimally invasive surgeries and the increasing prevalence of diseases such as arthritis, cancer and cardiovascular diseases
·         The Digital imaging (3D/2D) technology holds the largest market share in the year 2015 that use CMOS / 3CCD image sensors. However, CMOS digital imaging is expected to replace CCD technology due to certain advantages such as less power consumption and increased consolidation.
·         Dermatology is anticipated to exhibit highest growth rate owing to increase in chronic dermatological diseases and complications and the subsequent rise in the use of medical cameras to diagnose dermatological conditions.
·         Asia-Pacific region is anticipated to record fastest growth owing to the continuous advancements in imaging technology, and increase in R&D in efforts to improve healthcare infrastructure. .
·         Some of the major key players in the market include Carestream Health, Inc., Canon, Inc., Olympus Corporation, and Stryker Corporation.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the medical cameras market on the basis of applications, technology and region:
Application Outlook (Revenue, USD Million; 2014 - 2025)
·         Endoscopy
·         Ophthalmology
·         Dermatology
·         Dental 
·         Others
Technology Outlook (Revenue, USD Million; 2014 - 2025)
·         Digital imaging (3D/2D)
·         Infrared
·         OCT (Optical Coherence Tomography)
·         Liquid lens technology
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
o    India
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
o    Saudi Arabia
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-medical-cameras-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com



Bioresorbable Polymer Market Is Anticipated To Grow Due To Growing Demand In The Medical Sector Till 2025 : Grand View Research, Inc.

The global bioresorbablepolymer market is anticipated to reach USD 2.26 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand in the medical sector, owing to its hydrolytically degrading property in the body is projected to increase the global market growth. 
The increasing health awareness, improving healthcare facilities worldwide and growing surgery procedures across the globe will have a positive impact on the bioresorbable polymers industry growth in the overcoming years.
The increasing product demand for drug delivery application is another key factor for market development over the forecast period. The harmless decomposition and its chemically neutral nature in the body make them suitable for drug delivery segment.
The PLA-based product demand exceeded 89 tons in 2015, which is projected to remain as the largest and fastest growing segment over the upcoming years. The PLA market is growing dramatically in the pharmaceutical sector owing to its distinctive feature of being biodegradable and biocompatible.
Further Key Findings from the Study Suggest:
·         The global bioresorbable polymers demand was over 298 tons in 2015 and is expected to grow at an estimated CAGR of 14.3% over the projected period
·         The PCL-based product market accounted for over 13% of the total revenue in 2015
·         Orthopedics was the leading application segment with demand exceeding 45% in 2015
·         The bioresorbable polymer market in drug delivery application is estimated to have the highest growth at a CAGR of over 14% from 2016 to 2025
·         The U.S. polyglycolic acid product market generated revenue worth of USD 31.5 million in 2015 and is expected to reach a total revenue of over USD 110 million by 2025
·         Polysaccharides demand in Europe is estimated to exceed a total revenue of USD 470 million by the end of forecast period
·         Factors such as changing consumption patterns, technological advancements, and rising government initiatives, are anticipated to influence the market in the overcoming years
·         Influential companies operating in this market include Carbion NV, Evonik Industries AG, Poly-Med, Inc., Foster Corporation and KLS Martin Group
·         Evonik and Carbion dominated the global market together accounting for over 50% of the total revenue in 2015
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers
Grand View Research has segmented the bioresorbable polymer market on the basis of product, application and region:
Bioresorbable Polymers Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Polysaccharides
·         Proteins
·         Polylactic acid
·         Polyglycolic acid
·         Polycaprolactone
·         Others
Bioresorbable Polymers Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Drug Delivery
·         Orthopedics
·         Others
Bioresorbable Polymers Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S
o    Canada
o    Mexico
·         Europe
o    Germany
o    UK
o    France
o    Italy
·         Asia Pacific
o    China
o    India
o    Japan
·         Middle East and Africa
·         Central & South America
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-bioresorbable-polymers-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com